H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 16.1% of adults in Paterson have diagnosed diabetes — 4.1 points above the U.S. 12% figure. Census population 159,732. New Jersey Medicare wound biologics: Novitas Solutions (JL). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Paterson clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Paterson storefront.
Platelet Rich Plasma (PRP) Therapy in Paterson, NJ for clinics & physicians. PRP therapy systems with 1-mi… Compliance support & pricing — contact Hawk Medical.
Adult arthritis here is 20% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. CDC PLACES (2023, crude) estimates 16.1% of adults in Paterson have diagnosed diabetes — 4.1 points above the U.S. 12% figure. Together those PLACES numbers are why a city under 250k still needs separate PRP and CTP protocols. platelet rich plasma therapy inventory is national; utilization is JL-local.
National Platelet Rich Plasma (PRP) Therapy notes (how the product actually works)JL reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Paterson is 16.1% or not. PLACES is planning data. The LCD is the claim.
Vendor consolidation is boring on purpose: one account, IFUs filed, JL articles mapped. 28.6% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Pricing scripts have to match that mix. We will help write them. We will not book your patients.
CDC PLACES (2023, crude prevalence) estimates 16.1% of adults — 4.1 points above the U.S. 12% figure. Obesity is 37.5%; arthritis is 20%. That is place-level BRFSS modeling, not a clinic census and not a Paterson trial.
New Jersey is in CMS MAC JL, administered by Novitas Solutions. CTP and skin-substitute coverage is written at the MAC level. Confirm the current LCD/article before you set utilization — we help practices map product to those rules; we do not override them.
Yes — receiving, storage, indication, and documentation templates are part of onboarding. SOPs still have to be adopted as the clinic’s own procedures; we do not pretend to be the medical director in Paterson.
A 510(k)-cleared device has a different regulatory file than a 361 HCT/P. Do not store, bill, or describe them as the same SKU family. Your SOP should split receiving and indication language.
If you operate in New Jersey and another MAC state, say it on the first call. JL will not port 1:1. We would rather split utilization than watch a sister clinic copy Paterson tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Paterson, NJ.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Paterson is JL geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Paterson — 4.1 points above the U.S. 12% figure. Planning input, not an outcomes claim.
New Jersey Part B wound biologics follow this contractor (siblings: DC, DE, MD, PA). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Paterson. Useful for joint-program math; still needs a diagnosis and privileging.
No Paterson storefront. Joe Bradley is an active practice owner. platelet rich plasma therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.